Bull
$3.12
Scenario price
$3.250
+0.041 (+1.25%)At close
Cronos Group Inc. is a global cannabinoid company focused on consumer goods products through research and development and innovation. The Company's diverse international brand portfolio includes Spinach, PEACE NATURALS, Lord Jones, LIT, and C.O.G. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, and edibles. Lord Jones is a premium cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer concentrates and edible categories. The Lord Jones brand products are available in the Israeli medical market with cannabis flower products. PEACE NATURALS is a global medical brand engaged in producing cannabis products. LIT is a value‑driven medical cannabis brand, which offers a focused lineup of dried flower products sold in medical markets across Israel, Germany and the United Kingdom.
Cronos Group Inc appears to be a good buy right now, especially considering its current price of $3.21 and a forward P/E ratio of 28.74. The company reported a remarkable 58% year-over-year increase in net revenue for Q2 2026, reaching $53 million, and its gross margin improved to 53.69%. These figures indicate strong financial performance and growth potential. However, the main risk is its current RSI of 45.12, which suggests it may be nearing oversold conditions, indicating potential volatility.
TD Securities
$7
2026-09-28
TD Securities
2026-09-28
Price Target
$7
TD Securities
—
2026-05-12
TD Securities
2026-05-12
Price Target
—
TD Securities
$4.50
2026-02-24
TD Securities
2026-02-24
Price Target
$4.50
Canaccord
$4.25
2026-01-27
Canaccord
2026-01-27
Price Target
$4.25
CIBC
$3.5
2024-05-15
CIBC
2024-05-15
Price Target
$3.5
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Cronos Acquires CanAdelaar for €57.5 Million, Establishing European Market Leadership

Cronos Group Reintroduces Seasonal Limited-Edition Products

Cannabis Stocks Outperform S&P 500: Trulieve and Cronos Shine

Goldman Sachs Raises Robinhood Price Target to $142

Cronos Expands Edible and Vape Product Line with New Flavors
Cronos Group Inc. is a global cannabinoid company focused on consumer goods products through research and development and innovation. The Company's diverse international brand portfolio includes Spinach, PEACE NATURALS, Lord Jones, LIT, and C.O.G. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, and edibles. Lord Jones is a premium cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer concentrates and edible categories. The Lord Jones brand products are available in the Israeli medical market with cannabis flower products. PEACE NATURALS is a global medical brand engaged in producing cannabis products. LIT is a value‑driven medical cannabis brand, which offers a focused lineup of dried flower products sold in medical markets across Israel, Germany and the United Kingdom. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).
Cronos Group Inc appears to be a good buy right now, especially considering its current price of $3.21 and a forward P/E ratio of 28.74. The company reported a remarkable 58% year-over-year increase in net revenue for Q2 2026, reaching $53 million, and its gross margin improved to 53.69%. These figures indicate strong financial performance and growth potential. However, the main risk is its current RSI of 45.12, which suggests it may be nearing oversold conditions, indicating potential volatility.
1 analysts cover CRON: 0 rate it Buy, 1 Hold and 0 Sell. The average price target is 2.72.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.